Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-31

Clinical Trial Update: Amodiaquine+Artesunate for Uncomplicated Malaria Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating amodiaquine plus artesunate for malaria has completed enrollment and status is updated to completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amodiaquine (Amodiaquine)
  • Artesunate (artesunate)

Snippet

Sponsor: Centre Muraz | Conditions: Uncomplicated Malaria | Phase 4 | Status: COMPLETED